Report Detail

Other Global CRISPR Genome Editing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM2806693
  • |
  • 02 August, 2024
  • |
  • Global
  • |
  • 125 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global CRISPR Genome Editing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR.
The Global Info Research report includes an overview of the development of the CRISPR Genome Editing industry chain, the market status of Biotechnology Companies (Genetic Engineering, Gene Library), Pharmaceutical Companies (Genetic Engineering, Gene Library), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CRISPR Genome Editing.
Regionally, the report analyzes the CRISPR Genome Editing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CRISPR Genome Editing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CRISPR Genome Editing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CRISPR Genome Editing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Genetic Engineering, Gene Library).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CRISPR Genome Editing market.
Regional Analysis: The report involves examining the CRISPR Genome Editing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CRISPR Genome Editing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CRISPR Genome Editing:
Company Analysis: Report covers individual CRISPR Genome Editing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CRISPR Genome Editing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Biotechnology Companies, Pharmaceutical Companies).
Technology Analysis: Report covers specific technologies relevant to CRISPR Genome Editing. It assesses the current state, advancements, and potential future developments in CRISPR Genome Editing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CRISPR Genome Editing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
CRISPR Genome Editing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Genetic Engineering
Gene Library
Human Stem Cells
Others
Market segment by Application
Biotechnology Companies
Pharmaceutical Companies
Others
Market segment by players, this report covers
Editas Medicine
CRISPR Therapeutics
Horizon Discovery
Sigma-Aldrich
Genscript
Sangamo Biosciences
Lonza Group
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Thermo Fisher Scientific
Caribou Biosciences
Precision Biosciences
Cellectis
Intellia Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRISPR Genome Editing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRISPR Genome Editing, with revenue, gross margin and global market share of CRISPR Genome Editing from 2019 to 2024.
Chapter 3, the CRISPR Genome Editing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRISPR Genome Editing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR Genome Editing.
Chapter 13, to describe CRISPR Genome Editing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of CRISPR Genome Editing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of CRISPR Genome Editing by Type
    • 1.3.1 Overview: Global CRISPR Genome Editing Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global CRISPR Genome Editing Consumption Value Market Share by Type in 2023
    • 1.3.3 Genetic Engineering
    • 1.3.4 Gene Library
    • 1.3.5 Human Stem Cells
    • 1.3.6 Others
  • 1.4 Global CRISPR Genome Editing Market by Application
    • 1.4.1 Overview: Global CRISPR Genome Editing Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Biotechnology Companies
    • 1.4.3 Pharmaceutical Companies
    • 1.4.4 Others
  • 1.5 Global CRISPR Genome Editing Market Size & Forecast
  • 1.6 Global CRISPR Genome Editing Market Size and Forecast by Region
    • 1.6.1 Global CRISPR Genome Editing Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global CRISPR Genome Editing Market Size by Region, (2019-2030)
    • 1.6.3 North America CRISPR Genome Editing Market Size and Prospect (2019-2030)
    • 1.6.4 Europe CRISPR Genome Editing Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific CRISPR Genome Editing Market Size and Prospect (2019-2030)
    • 1.6.6 South America CRISPR Genome Editing Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa CRISPR Genome Editing Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Editas Medicine
    • 2.1.1 Editas Medicine Details
    • 2.1.2 Editas Medicine Major Business
    • 2.1.3 Editas Medicine CRISPR Genome Editing Product and Solutions
    • 2.1.4 Editas Medicine CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Editas Medicine Recent Developments and Future Plans
  • 2.2 CRISPR Therapeutics
    • 2.2.1 CRISPR Therapeutics Details
    • 2.2.2 CRISPR Therapeutics Major Business
    • 2.2.3 CRISPR Therapeutics CRISPR Genome Editing Product and Solutions
    • 2.2.4 CRISPR Therapeutics CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 CRISPR Therapeutics Recent Developments and Future Plans
  • 2.3 Horizon Discovery
    • 2.3.1 Horizon Discovery Details
    • 2.3.2 Horizon Discovery Major Business
    • 2.3.3 Horizon Discovery CRISPR Genome Editing Product and Solutions
    • 2.3.4 Horizon Discovery CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Horizon Discovery Recent Developments and Future Plans
  • 2.4 Sigma-Aldrich
    • 2.4.1 Sigma-Aldrich Details
    • 2.4.2 Sigma-Aldrich Major Business
    • 2.4.3 Sigma-Aldrich CRISPR Genome Editing Product and Solutions
    • 2.4.4 Sigma-Aldrich CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Sigma-Aldrich Recent Developments and Future Plans
  • 2.5 Genscript
    • 2.5.1 Genscript Details
    • 2.5.2 Genscript Major Business
    • 2.5.3 Genscript CRISPR Genome Editing Product and Solutions
    • 2.5.4 Genscript CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Genscript Recent Developments and Future Plans
  • 2.6 Sangamo Biosciences
    • 2.6.1 Sangamo Biosciences Details
    • 2.6.2 Sangamo Biosciences Major Business
    • 2.6.3 Sangamo Biosciences CRISPR Genome Editing Product and Solutions
    • 2.6.4 Sangamo Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sangamo Biosciences Recent Developments and Future Plans
  • 2.7 Lonza Group
    • 2.7.1 Lonza Group Details
    • 2.7.2 Lonza Group Major Business
    • 2.7.3 Lonza Group CRISPR Genome Editing Product and Solutions
    • 2.7.4 Lonza Group CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Lonza Group Recent Developments and Future Plans
  • 2.8 Integrated DNA Technologies
    • 2.8.1 Integrated DNA Technologies Details
    • 2.8.2 Integrated DNA Technologies Major Business
    • 2.8.3 Integrated DNA Technologies CRISPR Genome Editing Product and Solutions
    • 2.8.4 Integrated DNA Technologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Integrated DNA Technologies Recent Developments and Future Plans
  • 2.9 New England Biolabs
    • 2.9.1 New England Biolabs Details
    • 2.9.2 New England Biolabs Major Business
    • 2.9.3 New England Biolabs CRISPR Genome Editing Product and Solutions
    • 2.9.4 New England Biolabs CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 New England Biolabs Recent Developments and Future Plans
  • 2.10 Origene Technologies
    • 2.10.1 Origene Technologies Details
    • 2.10.2 Origene Technologies Major Business
    • 2.10.3 Origene Technologies CRISPR Genome Editing Product and Solutions
    • 2.10.4 Origene Technologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Origene Technologies Recent Developments and Future Plans
  • 2.11 Transposagen Biopharmaceuticals
    • 2.11.1 Transposagen Biopharmaceuticals Details
    • 2.11.2 Transposagen Biopharmaceuticals Major Business
    • 2.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Product and Solutions
    • 2.11.4 Transposagen Biopharmaceuticals CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Transposagen Biopharmaceuticals Recent Developments and Future Plans
  • 2.12 Thermo Fisher Scientific
    • 2.12.1 Thermo Fisher Scientific Details
    • 2.12.2 Thermo Fisher Scientific Major Business
    • 2.12.3 Thermo Fisher Scientific CRISPR Genome Editing Product and Solutions
    • 2.12.4 Thermo Fisher Scientific CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.13 Caribou Biosciences
    • 2.13.1 Caribou Biosciences Details
    • 2.13.2 Caribou Biosciences Major Business
    • 2.13.3 Caribou Biosciences CRISPR Genome Editing Product and Solutions
    • 2.13.4 Caribou Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Caribou Biosciences Recent Developments and Future Plans
  • 2.14 Precision Biosciences
    • 2.14.1 Precision Biosciences Details
    • 2.14.2 Precision Biosciences Major Business
    • 2.14.3 Precision Biosciences CRISPR Genome Editing Product and Solutions
    • 2.14.4 Precision Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Precision Biosciences Recent Developments and Future Plans
  • 2.15 Cellectis
    • 2.15.1 Cellectis Details
    • 2.15.2 Cellectis Major Business
    • 2.15.3 Cellectis CRISPR Genome Editing Product and Solutions
    • 2.15.4 Cellectis CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Cellectis Recent Developments and Future Plans
  • 2.16 Intellia Therapeutics
    • 2.16.1 Intellia Therapeutics Details
    • 2.16.2 Intellia Therapeutics Major Business
    • 2.16.3 Intellia Therapeutics CRISPR Genome Editing Product and Solutions
    • 2.16.4 Intellia Therapeutics CRISPR Genome Editing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Intellia Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global CRISPR Genome Editing Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of CRISPR Genome Editing by Company Revenue
    • 3.2.2 Top 3 CRISPR Genome Editing Players Market Share in 2023
    • 3.2.3 Top 6 CRISPR Genome Editing Players Market Share in 2023
  • 3.3 CRISPR Genome Editing Market: Overall Company Footprint Analysis
    • 3.3.1 CRISPR Genome Editing Market: Region Footprint
    • 3.3.2 CRISPR Genome Editing Market: Company Product Type Footprint
    • 3.3.3 CRISPR Genome Editing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global CRISPR Genome Editing Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global CRISPR Genome Editing Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global CRISPR Genome Editing Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global CRISPR Genome Editing Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America CRISPR Genome Editing Consumption Value by Type (2019-2030)
  • 6.2 North America CRISPR Genome Editing Consumption Value by Application (2019-2030)
  • 6.3 North America CRISPR Genome Editing Market Size by Country
    • 6.3.1 North America CRISPR Genome Editing Consumption Value by Country (2019-2030)
    • 6.3.2 United States CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 6.3.3 Canada CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico CRISPR Genome Editing Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe CRISPR Genome Editing Consumption Value by Type (2019-2030)
  • 7.2 Europe CRISPR Genome Editing Consumption Value by Application (2019-2030)
  • 7.3 Europe CRISPR Genome Editing Market Size by Country
    • 7.3.1 Europe CRISPR Genome Editing Consumption Value by Country (2019-2030)
    • 7.3.2 Germany CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 7.3.3 France CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 7.3.5 Russia CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 7.3.6 Italy CRISPR Genome Editing Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific CRISPR Genome Editing Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific CRISPR Genome Editing Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific CRISPR Genome Editing Market Size by Region
    • 8.3.1 Asia-Pacific CRISPR Genome Editing Consumption Value by Region (2019-2030)
    • 8.3.2 China CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 8.3.3 Japan CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 8.3.5 India CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 8.3.7 Australia CRISPR Genome Editing Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America CRISPR Genome Editing Consumption Value by Type (2019-2030)
  • 9.2 South America CRISPR Genome Editing Consumption Value by Application (2019-2030)
  • 9.3 South America CRISPR Genome Editing Market Size by Country
    • 9.3.1 South America CRISPR Genome Editing Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina CRISPR Genome Editing Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa CRISPR Genome Editing Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa CRISPR Genome Editing Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa CRISPR Genome Editing Market Size by Country
    • 10.3.1 Middle East & Africa CRISPR Genome Editing Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia CRISPR Genome Editing Market Size and Forecast (2019-2030)
    • 10.3.4 UAE CRISPR Genome Editing Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 CRISPR Genome Editing Market Drivers
  • 11.2 CRISPR Genome Editing Market Restraints
  • 11.3 CRISPR Genome Editing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 CRISPR Genome Editing Industry Chain
  • 12.2 CRISPR Genome Editing Upstream Analysis
  • 12.3 CRISPR Genome Editing Midstream Analysis
  • 12.4 CRISPR Genome Editing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on CRISPR Genome Editing . Industry analysis & Market Report on CRISPR Genome Editing is a syndicated market report, published as Global CRISPR Genome Editing Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of CRISPR Genome Editing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report